Skip to content

Cingal

by Anika Therapeutics, Inc. 4 variants

Ref 695007

Cingal (695007) is a medical device (EU MDD Class III; EMDN category resorbable filling and reconstruction devices) made by Anika Therapeutics, Inc., registered in EUDAMED on 3 Nov 2026 (Basic UDI-DI B-00817337000166), active as of 7 Nov 2026.

Active European Union

CE MDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-00817337000166 Basic UDI-DI 00817337000166UDI-DIDate3 Nov 2026RegisteredStatusActive

Official records

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDD Active

Specification

EUDAMED

Model / reference
695007
Primary DI / UDI-DI
00817337000166
Basic UDI-DI
B-00817337000166
EMDN code
P900402 Resorbable filling and reconstruction devices
Device class
Class III
EU registration type
Legacy device (under a directive)
EU market of registration
Italy

Manufacturer details

EUDAMED SRN
US-MF-000041541
Authorised representative
ANIKA THERAPEUTICS S.R.L. IT-AR-000028142

Similar devices in this category

Other devices filed under RESORBABLE FILLING AND RECONSTRUCTION DEVICES.

Other devices from Anika Therapeutics, Inc.

See all devices from Anika Therapeutics, Inc. →

Properties

  • Supplied sterile
  • Implantable
  • Incorporates a medicinal substance
Other properties (9, all answered No)